Search Results - "Kotze, Paulo"

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease by Olivera, Pablo A., Zuily, Stephane, Kotze, Paulo G., Regnault, Veronique, Al Awadhi, Sameer, Bossuyt, Peter, Gearry, Richard B., Ghosh, Subrata, Kobayashi, Taku, Lacolley, Patrick, Louis, Edouard, Magro, Fernando, Ng, Siew C., Papa, Alfredo, Raine, Tim, Teixeira, Fabio V., Rubin, David T., Danese, Silvio, Peyrin-Biroulet, Laurent

“…Patients with inflammatory bowel disease (IBD) are at increased risk of thrombotic events. Therapies for IBD have the potential to modulate this risk. The aims…”
Get full text

Letter: is measurement of faecal biomarkers helpful for the early diagnosis and prediction of pouchitis after proctocolectomy for ulcerative colitis? by Yamamoto, Takayuki, Shimoyama, Takahiro, Kotze, Paulo G.

“…LINKED CONTENTThis article is linked to Kayal et al and Kayal and Ungaro papers. To view these articles, visit https://doi.org/10.1111/apt.15505 and…”
Get full text

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications by Maaser, Christian, Sturm, Andreas, Vavricka, Stephan R, Kucharzik, Torsten, Fiorino, Gionata, Annese, Vito, Calabrese, Emma, Baumgart, Daniel C, Bettenworth, Dominik, Borralho Nunes, Paula, Burisch, Johan, Castiglione, Fabiana, Eliakim, Rami, Ellul, Pierre, González-Lama, Yago, Gordon, Hannah, Halligan, Steve, Katsanos, Konstantinos, Kopylov, Uri, Kotze, Paulo G, Krustiņš, Eduards, Laghi, Andrea, Limdi, Jimmy K, Rieder, Florian, Rimola, Jordi, Taylor, Stuart A, Tolan, Damian, van Rheenen, Patrick, Verstockt, Bram, Stoker, Jaap

Get full text

Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab by Ma, Christopher, Kotze, Paulo G., Almutairdi, Abdulelah, Jairath, Vipul, Panaccione, Remo

“…Vedolizumab, a monoclonal antibody targeting α4β7 leukocyte integrins, has demonstrated efficacy for induction and maintenance of remission in ulcerative…”
Get full text

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects by Sturm, Andreas, Maaser, Christian, Calabrese, Emma, Annese, Vito, Fiorino, Gionata, Kucharzik, Torsten, Vavricka, Stephan R, Verstockt, Bram, van Rheenen, Patrick, Tolan, Damian, Taylor, Stuart A, Rimola, Jordi, Rieder, Florian, Limdi, Jimmy K, Laghi, Andrea, Krustiņš, Eduards, Kotze, Paulo G, Kopylov, Uri, Katsanos, Konstantinos, Halligan, Steve, Gordon, Hannah, González Lama, Yago, Ellul, Pierre, Eliakim, Rami, Castiglione, Fabiana, Burisch, Johan, Borralho Nunes, Paula, Bettenworth, Dominik, Baumgart, Daniel C, Stoker, Jaap

“…Copyright © 2018 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved Clinical indexes are useful for…”
Get full text

Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives by Papamichael, Konstantinos, Afif, Waqqas, Drobne, David, Dubinsky, Marla C, Ferrante, Marc, Irving, Peter M, Kamperidis, Nikolaos, Kobayashi, Taku, Kotze, Paulo G, Lambert, Jo, Noor, Nurulamin M, Roblin, Xavier, Roda, Giulia, Vande Casteele, Niels, Yarur, Andres J, Arebi, Naila, Danese, Silvio, Paul, Stephane, Sandborn, William J, Vermeire, Séverine, Cheifetz, Adam S, Peyrin-Biroulet, Laurent

“…Therapeutic drug monitoring (TDM) has emerged as a useful tool for optimising the use of biologics, and in particular anti-tumour necrosis factor (anti-TNF)…”
Get more information

Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap? by Kotze, Paulo Gustavo, Danese, Silvio

Get more information

Are the New Biologics Effective in the Management of Postoperative Crohn’s Disease? by Mourad, Fadi H, Maalouf, Rami G, Aoun, Roni, Gustavo Kotze, Paulo, Hashash, Jana G

“…Abstract Background Despite the growing therapeutic armamentarium, at least half of the patients with Crohn’s disease will require surgery during their…”
Get full text

COVID‐19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE‐IBD registry by Queiroz, Natália S F, Martins, Camilla de Almeida, Quaresma, Abel B, Hino, Adriano A F, Steinwurz, Flavio, Ungaro, Ryan C, Kotze, Paulo G

“…Background and Aim One of the most impacted regions by the pandemic globally, Latin America is facing socioeconomic and health‐care challenges that can…”
Get full text

The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil by Quaresma, Abel B, Kaplan, Gilaad G, Kotze, Paulo G

“…PURPOSE OF REVIEWEpidemiological studies of inflammatory bowel disease (IBD) in newly industrialized countries are limited, due to a lack of medical…”
Get full text

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme by Farraye, Francis A., Qazi, Taha, Kotze, Paulo G., Moore, Gregory T., Mundayat, Rajiv, Lawendy, Nervin, Sharma, Puza P., Judd, Donna T.

“…Summary Background Obesity may affect efficacy and safety of biologic treatments for ulcerative colitis (UC). Tofacitinib is an oral, small molecule Janus…”
Get full text

Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus by Olivera, Pablo A., Dignass, Axel, Dubinsky, Marla C., Peretto, Giovanni, Kotze, Paulo G., Dotan, Iris, Kobayashi, Taku, Ghosh, Subrata, Magro, Fernando, Faria-Neto, Jose Rocha, Siegmund, Britta, Danese, Silvio, Peyrin-Biroulet, Laurent

“…Janus kinase (JAK) inhibitors and sphingosine 1 phosphate (S1P) receptor modulators are small molecule drugs (SMDs) approved for IBD treatment. Their use in…”
Get full text

S1451 Efficacy and Safety Profile of Etrasimod Was Not Impacted by Baseline Disease Activity: A Post Hoc Analysis of the ELEVATE UC Program by Sands, Bruce E., Dubinsky, Marla C., Kotze, Paulo G., Vermeire, Séverine, Panaccione, Remo, Long, Millie D., Woolcott, John C., Wu, Joseph, McDonnell, Aoibhinn, Goetsch, Martina, Bananis, Eustratios, Yarur, Andres J.

Get full text

US National Estimates of Contemporary Mortality Rates in Patients with Ulcerative Colitis Undergoing Colectomy by Ahmed, Newaz Shubidito, Krawchuk, Satchel, Buhler, Katherine A, Solitano, Virginia, Jairath, Vipul, Shaheen, Abdel Aziz, Seow, Cynthia H, Novak, Kerri L, Ingram, Richard J M, Lu, Cathy, Kotze, Paulo G, Kaplan, Gilaad G, Panaccione, Remo, Ma, Christopher

“…Despite a growing armamentarium of medical therapies for ulcerative colitis (UC), colectomy remains an important therapeutic option. To better inform shared…”
Get full text

S962 Presence of Risk Factors Associated With Colectomy Among Patients With Colectomy in the Tofacitinib OCTAVE Ulcerative Colitis Clinical Program by Rubin, David T., Salese, Leonardo, Kotze, Paulo G., Woolcott, John C., Su, Chinyu, Mundayat, Rajiv, Paulissen, Jerome, Torres, Joana, Long, Millie

Get full text

European evidence based consensus on surgery for ulcerative colitis by Øresland, Tom, Bemelman, Willem, Sampietro, Gianluca, Spinelli, Antonino, Windsor, Alastair, Tiret, Emmanuel, Sica, Giuseppe, Panis, Yves, Faerden, Arne, Biancone, Livia, Angriman, Imerio, Serclova, Zuzana, De Buck, Anthony, Gionchetti, Paolo, Stassen, Laurents, Warusavitarne, Janindra, Adamina, Michel, Dignass, Axel, Eliakim, Rami, Magro, Fernando, D'Hoore, André

Get full text

Real‐world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease by Kotze, Paulo G., Ma, Christopher, Almutairdi, Abdulelah, Al‐Darmaki, Ahmed, Devlin, Shane M., Kaplan, Gilaad G., Seow, Cynthia H., Novak, Kerri L., Lu, Cathy, Ferraz, Jose G. P., Stewart, Michael J., Buresi, Michelle, Jijon, Humberto, Mathivanan, Meena, Heatherington, Joan, Martin, Marie‐Louise, Panaccione, Remo

“…Summary Background Vedolizumab is an α4β7 integrin antagonist with proven efficacy for inducing and maintaining clinical response and remission in Crohn's…”
Get full text

International Organization for the Study of IBD Recommendations for Surgery in Patients With IBD During the Coronavirus Disease 2019 Pandemic by Remzi, Feza H., Panis, Yves, Spinelli, Antonino, Kotze, Paulo G., Mantzaris, Gerassimos, Söderholm, Johan D., d’Hoore, André, Bemelman, Willem A., Yamamoto, Takayuki, Pemberton, John H., Tiret, Emmanuel, Øresland, Tom, Fleshner, Phillip

Get full text

Correlation between trough levels of infliximab and postoperative endoscopic recurrence in Crohn's disease patients submitted to ileocolonic resections by Baraúna, Fernanda S B, Magro, Daniela O, Miranda, Eron F, Marçal, Gustavo N, Nones, Rodrigo B, Kotze, Paulo G

“…The aim of this study was to evaluate serum levels of Infliximab (IFX) in patients with Crohn's disease (CD) who underwent an ileocolonic resection and to…”
Get full text

The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD) by Azhari, Hassan, King, James A., Coward, Stephanie, Windsor, Joseph W., Ma, Christopher, Shah, Shailja C., Ng, Siew C., Mak, Joyce W.Y., Kotze, Paulo G., Ben-Horin, Shomron, Loftus, Edward V., Lees, Charlie W., Gearry, Richard, Burisch, Johan, Lakatos, Peter L., Calvet, Xavier, Bosques Padilla, Francisco Javier, Underwood, Fox E., Kaplan, Gilaad G.

“…Peptic ulcer disease (PUD) is a common cause of hospitalization worldwide. We assessed temporal trends in hospitalization for PUD in 36 Organisation for…”
Get full text